JPM23, Day 1: BMS touts new launches as patent cliff looms; Regeneron's Eylea sales disappoint
Fierce Pharma
JANUARY 9, 2023
JPM23, Day 1: BMS touts new launches as patent cliff looms; Regeneron's Eylea sales disappoint. esagonowsky. Mon, 01/09/2023 - 09:55.
Let's personalize your content